000790 Chengdu huasun technology group Inc., LTD.
- 3.74
- +0.12+3.31%
Chengdu huasun technology group Inc., LTD. News
Huashen Technology (000790): Focusing on Medicine and Health, Xinhuashen Chases Dreams
Taihe Health (000790) in-depth study: Taihe Group takes ownership and starts strategic transformation
[Soochow Securities] Taihe Health: Taihe Group is in charge, starting the strategic transformation
Taihe Health (000790) dynamic follow-up report: business continues to improve and change its name shows the determination to focus on Great Health.
Huashen Group (000790): focus on building modern traditional Chinese medicine to tap the potential of existing varieties
[southwest Securities] investigation report of Huashen Group: focus on building modern traditional Chinese medicine and tapping the potential of existing varieties
Huashen Group (000790) Research report: focus on the gradual increase of the overall gross profit margin of the main pharmaceutical industry
[southwest Securities] Huashen Group: focus on the main pharmaceutical industry, the overall gross profit margin gradually increased
[Huatai United Securities] Huashen Group 2010 Annual report comments: the performance is real, the future is worth looking forward to
[Xiangcai Securities] Huashen Group: the IV clinical report of Likatin meets expectations, which is good for academic promotion.
[Huatai United Securities] comments on the summary report of the phase iv clinical trial of Likatin in Huashen Group: the cloud of doubt gradually dissipates and the eagle flutters its wings.
【湘财证券】华神集团:毛利显著提高预示利卡汀突破推广瓶颈
【湘财证券】华神集团:突破 进取,生物健康产业之路前程似锦
【湘财证券】华神集团:利卡汀突破瓶颈,生物产业前景光明
【天相投资】华神集团:医药业务收入增长40.86%,利卡汀表现低于预期
【华泰联合证券】华神集团:是偶像派更是实力派
【华泰联合证券】华神集团:单抗先锋,涅磐在即
【广发证券】华神集团:借助单抗药物或许实现业绩拐点
【天相投资】华神集团:收入规模下降,股权激励成本摊销拖累净利润
【天相投资】华神集团:革命尚未成功,同志仍需努力
Analysis
Price Target
No Data
No Data